ClinicalTrials.gg
RecruitingNCT05743439Updated Apr 5, 2024

Early Augmentative and Alternative Communication (AAC) Intervention Delivered Via Hybrid Telehealth

An interventional study of Early Augmentative and Alternative Communication (AAC) Intervention in Intellectual Disability and Speech and Language Disorder, sponsored by Oregon Health and Science University. Recruiting at 1 site in United States. Open to participants aged 24 Months and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-04-05.

Sponsored by Oregon Health and Science University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Jun 2025, 1 year 5 months ago, but the record still lists the study as recruiting.
  • Registered 7 months after the study started (first participant enrolled Jul 2022, registered Feb 2023).
  • Started Jul 2022; still recruiting 4 years 4 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Not applicable
Ages
24 Months and older
Sex
All
01

Study summary

The goal of this mixed methods study aims to develop and pilot test an augmentative and alternative communication (AAC) intervention for toddlers with intellectual and developmental disabilities (IDD) and their families. The main question it aims to answer is: Will this AAC intervention improve caregivers' use of naturalistic AAC intervention strategies, leading to increases in children's communication? The investigators will employ qualitative methods to conduct interviews to determine caregiver and speech-language pathologist preferences regarding an AAC intervention. Findings from these interviews will inform the adaptation of the AAC intervention procedures, service delivery approach, and strategies to increase caregiver's treatment adherence. Next, the researchers will conduct six multiple baseline designs across behaviors (AAC strategies) to develop the AAC intervention and demonstrate preliminary efficacy when delivered to families in-person. Caregiver-child dyads will receive 24 in-person intervention sessions during which the therapist will provide AAC instruction and coaching on using AAC strategies to caregivers. Last, the investigators will pilot test the AAC intervention using a hybrid telehealth model with nine caregiver-child dyads. Caregiver-child dyads will receive 24 intervention sessions, eight sessions provided to families in-person, and 16 sessions provided to families via telehealth.

Our long-term goal is to develop a socially valid and effective intervention to improve language outcomes for toddlers with IDD. The researchers propose developing and pilot testing a hybrid telehealth AAC intervention for toddlers with IDD and their families. Researchers employ an implementation science approach, using systematic qualitative methods to identify caregivers' preferences and single-case experimental design methods to assess the feasibility of the AAC intervention. The central hypothesis is that the intervention will improve caregivers' use of naturalistic AAC intervention strategies, leading to increases in children's communication.

Read the detailed description

Aim 1: Determine stakeholders' preferences and needs for two key AAC intervention components: (a) service delivery and (b) strategies to enhance treatment adherence. Researchers will conduct and analyze interviews with ten caregivers and ten speech-language pathologists (SLPs) to assess the acceptability of different service delivery models (e.g., in person, telehealth, hybrid). Interviews will also focus on identifying strategies (e.g., text-message reminders, video modeling) with the potential to support caregivers' adherence and promote generalization to new activities. Results will inform AAC intervention development (Aim 2).

Aim 2: Develop an AAC intervention through iterative testing cycles. Researchers will conduct six multiple-baseline designs to investigate the effects of an AAC intervention on caregivers' AAC intervention strategy use (primary outcome) and children's communication acts (secondary outcome). Six caregiver-child dyads will receive 24 in-person intervention sessions, during which the therapist will teach caregivers to use AAC and language facilitation strategies during family-selected routines. Social validity will be assessed via weekly questionnaires and a post-intervention interview. In this experiment, the feasibility of in-person delivery is investigated to establish the acceptability and effects of the intervention procedures before pilot testing hybrid delivery. Results will inform modifications which will be tested in a hybrid delivery model (Aim 3).

Aim 3: Conduct a pilot test of a hybrid telehealth AAC intervention. Researchers will employ a combination multiple probe design to investigate the feasibility of a hybrid telehealth AAC intervention. Nine caregiver-child dyads will receive 24 intervention sessions (8 in-person, 16 telehealth) which include coaching on AAC and language facilitation strategies. The investigators hypothesize that the intervention will increase caregivers' AAC intervention strategy use (primary outcome) and children's communication acts (secondary outcome). Child communication outcomes and caregivers' social validity assessments will be explored to inform a future large-scale trial.

02

Conditions studied

  • Intellectual Disability
  • Speech and Language Disorder
03

In context

Intellectual Disability

387 studies on the registry are indexed under Intellectual Disability; 105 are open to participants now.

This study's planned enrollment of 50 is below the median of 58 across 248 interventional studies indexed under Intellectual Disability.

Browse Intellectual Disability studies →

Lead sponsor

Oregon Health and Science University is the lead sponsor of 696 studies on the registry; 131 are open to participants now.

Of its 52 completed or terminated interventional studies of FDA-regulated products, 39 (75%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
24 Months and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

  1. Speech-Language Pathologists:

    1. age > 18 years
    2. full or part-time employment providing language intervention to children 24 - 36 months with IDD
    3. has at least 1 child on their caseload who uses AAC
    4. has 2 or more years of experience providing AAC to children with IDD
    5. able to speak, understand, and read English.
  2. Caregivers:

    1. age > 18 years
    2. parent, primary caregiver, or legal guardian of a child age 24 - 36 months with IDD
    3. has at least 6 months of experience receiving early intervention, and
    4. able to speak, understand, and read English.
  3. Children:

    1. age 24 - 36 months
    2. diagnosis of IDD confirmed by caregiver or medical record
    3. severe developmental delay, defined as a score of > 2 standard deviations below the mean on the Mullen Scales of Early Learning (MSEL) Early Learning Composite
    4. severe expressive language impairment, defined as a score of \< 12 months on the Expressive Language Subscale of the MSEL and expressive vocabulary and \< 10 words (signs, or symbols) per caregiver report on the MacArthur-Bates Communicative Development Inventories Words and Gestures (MCDI-WG)
    5. receptive vocabulary of at least 50 words, per caregiver report on MCDI-WG
    6. use of intentional communication behaviors, defined as a score of > 7 on the Communication Complexity Scale
    7. sufficient motor skills to sit upright with support, interact with toys provided during the assessment, and access the AAC system
    8. hearing within normal limits, defined as 0 to 25 dbHL in at least one ear
    9. vision within normal limits, defined as 20/80 visual acuity or better in at least one eye, and
    10. exposure to English in the home or community.
    11. Children with uncontrolled seizure disorders will be excluded.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    Early Augmentative and Alternative Communication (AAC) Intervention

    After a period of stable baseline performance (3 to 5 sessions) on parent and child outcomes, the interventionist will apply the early AAC intervention.

    Behavioral: Early Augmentative and Alternative Communication (AAC) Intervention

Interventions

  • BehavioralEarly Augmentative and Alternative Communication (AAC) Intervention

    Caregivers will receive 24, 50 min intervention sessions twice a week for three months. During each intervention session, the therapist provides instruction and coaching on using AAC and a set of evidence-based language support strategies. Strategies are taught sequentially in three phases: (1) Responding to all Communication, (2) Teaching Words, and (3) Creating Communication Opportunities. Caregivers practice using the AAC intervention strategies during three, five-minute routines with their children. Therapists coach the caregiver on using the targeted strategies during these routines, encouraging caregivers to reflect on their implementation, and developing a plan to use the AAC strategies during activities not practiced during the intervention session. The AAC intervention is provided to families using an evidence-based service delivery model, Family Guided Routines Based Intervention.

06

What researchers measure

Primary outcomes

  1. Change in Caregiver Use of AAC Intervention Strategies

    Observational assessment of caregivers' use of AAC strategies during a 15-min caregiver-child interaction. The primary dependent variable is the caregiver's use of AAC strategies. The metric is the accuracy of AAC strategy use calculated by (correct strategy steps/ total strategy steps X100).

    Time frame: Assessed 1-2 times per week through study completion, 3-4 months.

Secondary outcomes

  1. Change in Number of Child Communication Acts

    Observational measure of a child's expressive communication behaviors including gestures, vocalizations, spoken words, manual signs, and picture symbols during a 15-min caregiver-child interaction. The secondary dependent variable is the number of child communication acts expressed. The metric is a frequency count of total child communication acts.

    Time frame: Assessed 1-2 times per week through study completion, 3-4 months.

Other outcomes

  1. Change in Acceptability of Intervention Measure (AIM)

    Informant-reported measure of the acceptability of an intervention and/or implementation strategy. This four item questionnaire is administered to determine the extent to which stakeholders believe an intervention (e.g., AAC intervention) or implementation strategy (e.g., training, coaching) is acceptable. This measure was designed to be pragmatic, and adapted to an intervention, organization, or population. This measure has substantive and discriminant content validity, structural validity (Cronbach's alpha = 0.85) and test-test reliability (Cronbach's alpha = 0.83). The metric is a total score with a range of 4 - 20. Higher scores indicate greater acceptability.

    Time frame: Measured weekly during baseline, intervention, and post-intervention. Through study completion, 3-4 months

  2. Change in Intervention Appropriateness Measure (IAM)

    Informant-reported measure of the appropriateness of an intervention and/ or implementation strategy. This four item questionnaire is administered to determine the extent to which stakeholders believe an intervention (e.g., AAC intervention) or implementation strategy (e.g., training, coaching) is appropriate. The measure was designed to be pragmatic, and adapted to an intervention, organization, or population. This measure has substantive and discriminant content validity, structural validity (Cronbach's alpha = 0.91) and test-test reliability (Cronbach's alpha = 0.87). The metric is a total score with a range of 4 - 20. Higher scores indicate greater appropriateness.

    Time frame: Measured weekly during baseline, intervention, and post-intervention. Through study completion, 3-4 months

  3. Change in Feasibility of Intervention Measure (FIM)

    Informant-reported measure of the feasibility of an intervention and/or implementation strategy. This four item questionnaire is administered to determine the extent to which stakeholders believe an intervention (e.g., AAC intervention) or implementation strategy (e.g., training, coaching) is feasible. The measure was designed to be pragmatic, and adapted to an intervention, organization, or population. This measure has substantive and discriminant content validity, structural validity (Cronbach's alpha = 0.89) and test-test reliability (Cronbach's alpha = 0.88). The metric is a total score with a range of 4 - 20. Higher scores indicate greater feasibility.

    Time frame: Measured weekly during baseline, intervention, and post-intervention. Through study completion, 3-4 months

  4. Change in Communication Complexity Scale (CCS; Aim 3 Only)

    Scripted assessment protocol with activities designed to elicit forms of communication. This assessment is used to describe the expressive communication skills of individuals who communicate using pre-symbolic and early symbolic behaviors. The CCS has adequate inter-observer agreement(k = 0.83), test-retest reliability ( r = 0.84), and concurrent validity with the Vineland II Expressive Communication Subscale (r = 0.47. The metric is the total optimal score with a range of 0 - 12. Higher scores indicate greater communication skills.

    Time frame: Study entry (start of study) and post-intervention (3-4 months later)

  5. Change in Communication Matrix (Aim 3 Only)

    Assessment consisting of 24 questions to describe early expressive communication skills of individuals who primarily communicate using pre-symbolic and early symbolic behaviors. This Communication Matrix has high inter-rater reliability (0.96). The metric is a total score with a range of 0 - 160. Higher scores indicate greater communication skills.

    Time frame: Study entry (start of study) and post-intervention (3-4 months later)

  6. Change in Preschool-Language Scales 5th Edition (Aim 3 Only)

    Standardized Assessment of expressive and receptive language skills. The metric is the total standard score with a mean of 100 and SD of 15

    Time frame: Study Entry (start of study) and Post Intervention (3-4 months later)

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — The final data set will include caregiver and SLP interview transcripts, standardized cognitive and language assessments, caregiver-reported demographic and behavioral data, observational data of the children in their caregivers at home over time and social validity questionnaires. This data set will be stripped of identifiers prior to release for sharing. We will make the data and associated documentation available to users only under a data-sharing agreement that provides for a commitment: (1) to use the data only for research purposes and not to identify any individual participant, (2) to secure the data using appropriate computer technology, (3) to destroy or return the data after analyses are completed, and (4) to cite the grant and key publications describing the database and measures in any resulting presentations and publications.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report

Time frame: Data will be available one year after all of the data analysis is complete.

Access criteria: We will make the data and associated documentation available to users only under a data-sharing agreement that provides for a commitment: (1) to use the data only for research purposes and not to identify any individual participant, (2) to secure the data using appropriate computer technology, (3) to destroy or return the data after analyses are completed, and (4) to cite the grant and key publications describing the database and measures in any resulting presentations and publications.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 5, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05743439
Responsible party
Emily Quinn (Principal Investigator, Oregon Health and Science University) — Principal investigator
First posted
Feb 24, 2023
Start date
Jul 1, 2022
Primary completion
Jun 1, 2025 (estimated)
Completion
Dec 31, 2025 (estimated)
Last update
Apr 5, 2024

Study contacts

Emily D. Quinn, Ph.D.
Contact
quinnem@ohsu.edu
503-494-2263
Alexandria Cook, B.A.
Contact
cooal@ohsu.edu
503-494-5179
Emily D. Quinn, Ph.D.
principal investigator · Oregon Health and Science University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion